
Registration is officially open for the JAFRAL Phage Summit 2026, the landmark global event bringing together clinicians, researchers, industry leaders, regulators, and innovators shaping the future of phage therapy.
Join us May 19–21, 2026, at the Grand Hotel Union in Ljubljana, Slovenia, for three days dedicated to advancing bacteriophage science, clinical practice, and antimicrobial resistance (AMR) solutions.
As phage therapy rapidly evolves and global interest intensifies, this summit offers a unique opportunity to connect with the community driving therapeutic phage development forward.

Phage therapy is reaching a critical turning point. With antibiotic resistance increasing worldwide, the medical community is urgently seeking alternatives that are effective, safe, and accessible. Bacteriophages — viruses that target and destroy bacteria — are emerging as one of the most promising tools in this fight.
At JAFRAL, our vision is clear:
As the world’s leading manufacturer of therapeutic-grade phages, JAFRAL is committed to bridging scientific innovation with patient needs — and this Summit is a key step in that mission.
The JAFRAL Phage Summit 2026 is designed to move the field forward by uniting expertise, sharing clinical evidence, and strengthening collaboration across disciplines.
A comprehensive look at the AMR crisis, the evolving role of phage therapy in modern healthcare, and opportunities for international scientific cooperation.
Key updates on ongoing trials, new clinical data, compassionate-use outcomes, and real-world experiences from physicians and researchers.
Practical insights into personalized phage treatments, regulatory perspectives, and the growing role of magistral preparations in patient care.
Phage therapy is evolving into a coordinated, global effort supported by clinicians, regulators, scientists, and industry.
If you want to contribute to shaping the next chapter of this field, the JAFRAL Phage Summit 2026 is where the global community comes together.